Sponsor

Kwang Dong Pharmaceutical co., ltd.

Clinical research sponsor

Published trials3

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

3 shown

To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight SubjectsNCT02462031 · lead sponsor · 2015-03-01

UNKNOWN

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male SubjectsNCT01979380 · lead sponsor · 2013-12-01

COMPLETED

Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity for RemissionNCT07753447 · collaborator · 2025-07-01

COMPLETED

Sponsor roles

lead sponsor2

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.